Immune cell therapy shows promise for tough lupus cases
Disease control
Ongoing
This early-stage study tests a new treatment called AB-101, made from natural killer cells, combined with antibody therapy for people with lupus nephritis or other hard-to-treat lupus. The goal is to see if it is safe and can help when standard treatments have failed. About 51 ad…
Phase: PHASE1 • Sponsor: Artiva Biotherapeutics, Inc. • Aim: Disease control
Last updated May 11, 2026 20:37 UTC